Skip to main content
Premium Trial:

Request an Annual Quote

UW, Nanogen Among Groups Awarded Grant to Develop Hand-Held Dx Tool

NEW YORK, July 7 (GenomeWeb News) - The University of Washington has won a $15.4 million grant as lead partner of a regional consortium to develop a "portable" diagnostic device.

The award is part of 43 other grants announced last week that won a total of $436 million from the nonprofit Grand Challenges in Global Health initiative. The grants went to industry and nonprofit groups, including PATH, Nanogen, and Micronics, each of which have "facilities" in Washington state, according to a UW statement.

 

The project aims to develop and test prototypes of a calculator-sized device that could be used in remote locations to diagnose diseases such as malaria and typhoid fever, the university said.

 

Additional details were not disclosed.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.